HUE043852T2 - A vastagbél kiürítésére szolgáló készítmények és a készítmények elõállítási módszerei - Google Patents

A vastagbél kiürítésére szolgáló készítmények és a készítmények elõállítási módszerei

Info

Publication number
HUE043852T2
HUE043852T2 HUE13822195A HUE13822195A HUE043852T2 HU E043852 T2 HUE043852 T2 HU E043852T2 HU E13822195 A HUE13822195 A HU E13822195A HU E13822195 A HUE13822195 A HU E13822195A HU E043852 T2 HUE043852 T2 HU E043852T2
Authority
HU
Hungary
Prior art keywords
formulations
methods
manufacturing
colonic evacuation
colonic
Prior art date
Application number
HUE13822195A
Other languages
English (en)
Inventor
Reza Fathi
Patrick Mclean
Original Assignee
Redhill Biopharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Redhill Biopharma Ltd filed Critical Redhill Biopharma Ltd
Publication of HUE043852T2 publication Critical patent/HUE043852T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HUE13822195A 2012-07-27 2013-07-26 A vastagbél kiürítésére szolgáló készítmények és a készítmények elõállítási módszerei HUE043852T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261676608P 2012-07-27 2012-07-27

Publications (1)

Publication Number Publication Date
HUE043852T2 true HUE043852T2 (hu) 2019-09-30

Family

ID=49997911

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE13822195A HUE043852T2 (hu) 2012-07-27 2013-07-26 A vastagbél kiürítésére szolgáló készítmények és a készítmények elõállítási módszerei

Country Status (25)

Country Link
US (3) US10166219B2 (hu)
EP (1) EP2877163B1 (hu)
JP (1) JP6454640B2 (hu)
KR (1) KR102152873B1 (hu)
CN (2) CN104797244B (hu)
AU (1) AU2013294737B2 (hu)
BR (1) BR112015001640A2 (hu)
CA (1) CA2880282C (hu)
CY (1) CY1121852T1 (hu)
DK (1) DK2877163T3 (hu)
ES (1) ES2717282T3 (hu)
HK (1) HK1212596A1 (hu)
HR (1) HRP20190550T1 (hu)
HU (1) HUE043852T2 (hu)
IL (1) IL236791B (hu)
IN (1) IN2015DN00637A (hu)
MX (1) MX366707B (hu)
NZ (1) NZ704014A (hu)
PH (1) PH12015500165A1 (hu)
PL (1) PL2877163T3 (hu)
PT (1) PT2877163T (hu)
RU (1) RU2015106688A (hu)
SI (1) SI2877163T1 (hu)
TR (1) TR201904884T4 (hu)
WO (1) WO2014016671A2 (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2651415T3 (pl) 2010-12-13 2021-04-19 Rite-Prep Pty Ltd. Formulacje dożołądkowe i dookrężnicze oraz sposoby ich wytwarzania i zastosowania
HUE043852T2 (hu) 2012-07-27 2019-09-30 Redhill Biopharma Ltd A vastagbél kiürítésére szolgáló készítmények és a készítmények elõállítási módszerei
IN2013MU02911A (hu) * 2013-09-10 2015-07-03 Cadila Healthcare Ltd
KR101420315B1 (ko) 2014-03-19 2014-07-17 남봉길 약학적 액제 조성물
CN109310774A (zh) 2015-08-17 2019-02-05 费林股份公司 含有匹可硫酸盐和柠檬酸镁的液体制剂
AR108992A1 (es) * 2016-07-08 2018-10-17 Ferring Bv Formulaciones líquidas estabilizadas que contienen picosulfato
EP3345591A1 (en) * 2017-01-06 2018-07-11 Oystershell NV Oral dosage form for enhanced solubilization of a poorly soluble active agent and method of preparation

Family Cites Families (116)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3459863A (en) * 1966-10-14 1969-08-05 Merck & Co Inc Color-stable ascorbic acid tablet
US4186025A (en) 1975-09-25 1980-01-29 Merck & Co., Inc. Aqueous polysaccharide composition
US4452779A (en) 1982-02-03 1984-06-05 Cockerill Vernon Composition and method of treating lactating mammals
DK454683D0 (da) 1983-10-03 1983-10-03 Mogens Gjerloev Tarmreguleringsmiddel til behandling af diarre hos dyr samt anvendelse heraf
SG72632A1 (en) 1985-04-18 2000-05-23 Procter & Gamble Treatment of non-ulcer dyspepsia with bismuth salts
US4766004A (en) 1986-12-19 1988-08-23 Warner-Lambert Company Crunchy, highly palatable, bulk-increasing, dietary fiber supplement composition
IL86859A (en) 1987-07-10 1991-12-15 E Z Em Inc Aqueous cathartic solution containing inorganic salts
DE3887353T2 (de) 1987-10-12 1994-05-05 Capability Services Pty Ltd Behandlungsverfahren für magen-darm-krankheiten.
AU2900889A (en) 1987-12-24 1989-07-19 Thomas Julius Borody Orthostatic lavage solutions
US5443826A (en) 1988-08-02 1995-08-22 Borody; Thomas J. Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
CA1333564C (en) 1988-08-02 1994-12-20 Thomas Julius Borody Treatment of gastro-intestinal disorders
US5213807A (en) 1990-05-03 1993-05-25 Chemburkar Pramod B Pharmaceutical composition containing ibuprofen and a prostaglandin
US5232699A (en) 1990-07-26 1993-08-03 The Proctor & Gamble Company Laxative compositions
ATE256468T1 (de) 1990-10-22 2004-01-15 Gastro Services Pty Ltd Behandlung von nicht-entzündlichen darmerkrankungen
US5519014A (en) 1990-10-22 1996-05-21 Borody; Thomas J. Treatment of non-inflammatory and non-infectious bowel disorders
US5173296A (en) 1990-11-16 1992-12-22 The Procter & Gamble Company Compositions containing psyllium
JPH06132767A (ja) 1992-10-22 1994-05-13 Rohm Co Ltd 圧電発振子
AU6251094A (en) 1993-02-26 1994-09-14 Procter & Gamble Company, The Bisacodyl dosage form
JP2974550B2 (ja) * 1993-06-01 1999-11-10 ビオフェルミン製薬株式会社 経口投与用固体組成物
AU7961094A (en) * 1993-10-19 1995-05-08 Procter & Gamble Company, The Picosulphate dosage form
JP3850891B2 (ja) 1994-03-01 2006-11-29 ゼリア新薬工業株式会社 緩下効果を有する組成物
AUPM695294A0 (en) 1994-07-20 1994-08-11 Borody, Thomas Julius Improved combination therapy dose unit
AUPM864894A0 (en) 1994-10-07 1994-11-03 Borody, Thomas Julius Treatment of bowel-dependent neurological disorders
RU2098100C1 (ru) 1995-10-11 1997-12-10 Максимова Ирина Сергеевна Ирригационный раствор для офтальмологических операций
NZ333493A (en) 1995-11-03 2000-06-23 Nicolas Peter Shortis Method of evacuating a patient's colon by oral administration of an osmotic colonic evacuant in powder form
AUPN634595A0 (en) 1995-11-03 1995-11-30 Borody, Thomas Julius Improved method for colonic evacuation
AU771576B2 (en) 1995-11-03 2004-03-25 Red Hill Biopharma Ltd. Improved preparation for colonic evacuation
US6103268A (en) 1995-11-03 2000-08-15 Borody; Thomas Julius Administering osmotic colonic evacuant containing a picosulfate
US6087386A (en) 1996-06-24 2000-07-11 Merck & Co., Inc. Composition of enalapril and losartan
AU713462B2 (en) * 1996-07-12 1999-12-02 Daiichi Pharmaceutical Co., Ltd. Quickly disintegrable compression-molded materials and process for producing the same
US5948787A (en) 1997-02-28 1999-09-07 Alza Corporation Compositions containing opiate analgesics
US6162464A (en) 1997-03-31 2000-12-19 Inkine Pharmaceutical, Inc. Non-aqueous colonic purgative formulations
US6551632B2 (en) 1997-04-01 2003-04-22 Thomas Julius Borody Methods and compositions for treating inflammatory bowel disease
ES2303351T3 (es) 1997-04-01 2008-08-01 Thomas Julius Borody Metodos y composiciones para tratar enfermedades intestinales inflamatorias.
CA2287442A1 (en) 1997-04-18 1998-10-29 Taisho Pharmaceutical Co., Ltd. Microemulsion
AUPO665397A0 (en) 1997-05-07 1997-05-29 Borody, Thomas Julius Novel therapy for constipation
AR016827A1 (es) 1997-08-22 2001-08-01 Smithkline Beecham Corp PROCEDIMIENTO PARA LA PREPARACIoN DE UNA TABLETA FARMACÉUTICA
ZA987592B (en) * 1997-08-22 1999-02-22 Smithkline Beecham Corp Rapdily disintegrating methylcellulose tablets
AR017512A1 (es) * 1997-08-22 2001-09-12 Smithkline Beecham Corp Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas
JP4092748B2 (ja) 1997-09-05 2008-05-28 ニプロ株式会社 腸管洗浄液
US5843477A (en) * 1997-09-30 1998-12-01 Bayer Corporation Lubricants for use in tabletting
NZ505123A (en) 1997-12-19 2003-07-25 Smithkline Beecham Corp Process for manufacturing bite-dispersion tablets by compressing medicaments and other ingredients into granulates then compressing the granulates and other ingredients into tablets, and the tablets thereof
AUPP325398A0 (en) 1998-04-30 1998-05-21 Borody, Thomas J. Improved method for eradicating h. pylori
AUPP437698A0 (en) 1998-06-30 1998-07-23 Baumgart, Karl Methods for treatment of coronary, carotid and other vascular disease
EP1005863A1 (en) 1998-12-04 2000-06-07 Synthelabo Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
US6245740B1 (en) 1998-12-23 2001-06-12 Amgen Inc. Polyol:oil suspensions for the sustained release of proteins
CA2363842C (en) 1999-02-26 2006-01-10 Shionogi & Co., Ltd. Chewable soft capsule having improved ingestion property and method for producing the same
US6858403B2 (en) 1999-05-11 2005-02-22 M-Biotech, Inc. Polymer matrix containing catalase co-immobilized with analytic enzyme that generates hydrogen peroxide
DE19930030B4 (de) 1999-06-30 2004-02-19 Meduna Arzneimittel Gmbh CO-3-ungesättigte Fettsäuren enthaltende orale Darreichungsform
CN1288730A (zh) 1999-09-07 2001-03-28 麦克内尔-Ppc股份有限公司 轻泻组合物
US6774111B1 (en) 2000-03-14 2004-08-10 Abbott Laboratories Carbohydrate system and a method for providing nutrition to a diabetic
CA2406067A1 (en) 2000-04-19 2001-11-01 Thomas Julius Borody Compositions comprising the combination of a bile acid and a fibrate for use in therapies for hyperlipidaemia-associated disorders
US20030180260A1 (en) 2000-06-19 2003-09-25 Clancy Robert Llewellyn Immunotherapy or treating bacterial or viral infection at mucosal surfaces with probiotics, and compositions therefor
AUPQ854100A0 (en) 2000-07-03 2000-07-27 Helirad Pty Ltd Methods for monitoring treatment of helicobacter infection
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
ES2248521T3 (es) 2001-02-27 2006-03-16 Ranbaxy Laboratories, Ltd. Composicion farmaceutica oral de cefpodoxima proxetilo.
US20020192345A1 (en) 2001-03-13 2002-12-19 John Kepplinger Aerated food component
US6790453B2 (en) 2001-03-14 2004-09-14 Mccormick & Company, Inc. Encapsulation compositions and process for preparing the same
US7815956B2 (en) 2001-04-27 2010-10-19 Pepsico Use of erythritol and D-tagatose in diet or reduced-calorie beverages and food products
DE60237087D1 (de) 2001-06-01 2010-09-02 Pozen Inc Pharmazeutische zusammensetzungen für die koordinierte abgabe von nsaid
US7846475B2 (en) 2001-07-05 2010-12-07 Wakunaga Pharmaceutical Co., Ltd. Soft capsules
US20030092724A1 (en) 2001-09-18 2003-05-15 Huaihung Kao Combination sustained release-immediate release oral dosage forms with an opioid analgesic and a non-opioid analgesic
AUPS017702A0 (en) 2002-01-25 2002-02-14 Atopic Pty Ltd Methods and compositions for the treatment of asthma and related disorders
AUPS088702A0 (en) 2002-03-04 2002-03-28 Borody, Thomas Julius Electrolyte purgative
US6753009B2 (en) 2002-03-13 2004-06-22 Mcneil-Ppc, Inc. Soft tablet containing high molecular weight polyethylene oxide
KR20040098050A (ko) 2002-04-05 2004-11-18 유로-셀띠끄 소시에떼 아노님 옥시코돈 및 날록손을 포함하는 약제학적 제제
US6946149B2 (en) 2002-04-30 2005-09-20 Braintree Laboratories, Inc. Salt solution for colon cleansing
JP4591742B2 (ja) * 2003-01-06 2010-12-01 大正製薬株式会社 ジオクチルソジウムスルホサクシネート配合製剤およびその製造方法
AU2003900553A0 (en) 2003-02-10 2003-02-20 Borody, Thomas Julius Novel Improved Method for Detection of Dientamoeba fragilis and other Parasites
US20040259899A1 (en) 2003-04-08 2004-12-23 Sanghvi Suketu P. Combination therapy for constipation
EP1620075B1 (en) 2003-05-07 2020-06-24 Samyang Biopharmaceuticals Corporation Highly plastic granules for making fast melting tablets
US20040265378A1 (en) 2003-06-25 2004-12-30 Yingxu Peng Method and compositions for producing granules containing high concentrations of biologically active substances
US7687075B2 (en) * 2003-11-19 2010-03-30 Salix Pharmaceuticals, Ltd. Colonic purgative composition with soluble binding agent
JP2005255595A (ja) * 2004-03-10 2005-09-22 Taisho Pharmaceut Co Ltd ジオクチルソジウムスルホサクシネート配合錠剤
JP2005272401A (ja) 2004-03-25 2005-10-06 Tendou Seiyaku Kk チュアブル錠
CA2559239C (en) 2004-04-13 2021-04-06 Boehringer Ingelheim International Gmbh Use of simethicone and sodium picosulphate in constipated patients suffering from bloated feeling and gas discomfort during the night
KR100749229B1 (ko) 2005-04-29 2007-08-13 (주)아모레퍼시픽 당 및 당알콜을 함유하는 변비개선용 조성물
US20060275223A1 (en) 2005-06-02 2006-12-07 Burr James B Erythritol compositions for teeth and gums
DE102006033014A1 (de) 2005-09-13 2007-04-05 Volkswagen Ag Eingabevorrichtung für ein Kraftfahrzeug
WO2007057924A1 (en) 2005-11-21 2007-05-24 Panacea Biotec Ltd Laxative composition on the basis of triphala
WO2007073702A2 (es) 2005-12-29 2007-07-05 Osmotica Corp. Comprimido multicapa con combinación de triple liberación
JP5006567B2 (ja) 2006-04-14 2012-08-22 花王株式会社 口腔用固形製剤
EP2068837A2 (en) 2006-07-28 2009-06-17 Dr. Reddy's Laboratories Ltd. Granular pharmaceutical compositions
WO2008021394A2 (en) 2006-08-15 2008-02-21 Theraquest Biosciences, Llc Pharmaceutical formulations of cannabinoids and method of use
WO2008027442A2 (en) 2006-08-30 2008-03-06 Theraquest Biosciences, Llc Abuse deterrent oral pharmaceutical formulations of opioid agonists and method of use
EP2094794B1 (en) 2006-12-04 2010-06-23 E.I. Du Pont De Nemours And Company Acrylic polyol coating composition
NZ580999A (en) 2007-05-17 2012-05-25 David Lubowski Combination laxative compositions comprising a colonic stimulant and a bulking laxative
CA2687192C (en) 2007-06-04 2015-11-24 Egalet A/S Controlled release pharmaceutical compositions for prolonged effect
CN101707930B (zh) 2007-06-06 2013-10-30 巴斯夫欧洲公司 用于制备快速崩解的片剂的药物配制剂
US20100184785A1 (en) 2007-06-06 2010-07-22 Basf Se Pharmaceutical formulation for the production of chewable tablets and lozenges
US20100255307A1 (en) 2007-07-27 2010-10-07 Cargill Inc. Micronization of polyols
EP2196221A4 (en) 2007-09-27 2011-12-28 Mitsubishi Tanabe Pharma Corp SOLID PREPARATION WITH QUICK DISINTEGRATION
KR101626873B1 (ko) 2007-10-01 2016-06-02 라보라토리오스 레스비, 에스.엘. 구강붕해정제
PL2207526T3 (pl) * 2007-10-12 2018-06-29 Ferring International Center S.A. Sposób wytwarzania produktu farmaceutycznego zawierającego kwas cytrynowy, tlenek magnezu, wodorowęglan potasu i pikosiarczan sodu, kompozycja farmaceutyczna zawierająca granulki otrzymane takim sposobem i jego produkty pośrednie
CN101406457A (zh) * 2007-10-12 2009-04-15 辉凌国际制药（瑞士）有限公司 制备药物产品的方法
US20100222311A1 (en) 2007-10-19 2010-09-02 Purdue Research Foundation Solid formulations of crystalline compounds
JP5258268B2 (ja) 2007-11-19 2013-08-07 フロイント産業株式会社 球形粒の製造方法
US20090155363A1 (en) 2007-12-14 2009-06-18 Todd Maibach Methods for oral administration of active drugs
US20090169622A1 (en) * 2007-12-27 2009-07-02 Roxane Laboratories, Inc. Delayed-release oral pharmaceutical composition for treatment of colonic disorders
JP5352474B2 (ja) 2007-12-28 2013-11-27 沢井製薬株式会社 口腔内崩壊錠およびその製造方法
US20090258090A1 (en) 2008-04-11 2009-10-15 Braintree Laboratories, Inc. Colon cleansing solution
US20100178413A1 (en) 2008-12-17 2010-07-15 Mark Gorris Food-based Supplement Delivery System
US20100285164A1 (en) 2009-05-11 2010-11-11 Jrs Pharma Orally Disintegrating Excipient
US20120064133A1 (en) 2009-05-28 2012-03-15 Ishwar Chauhan Multiparticulate Controlled-Release Selective Serotonin Reuptake Inhibitor Formulations
JP2011019046A (ja) 2009-07-08 2011-01-27 Nec Commun Syst Ltd 通信制御装置、通信制御方法、プログラム、及び記録媒体
WO2011019045A1 (ja) * 2009-08-11 2011-02-17 富士化学工業株式会社 崩壊性粒子組成物及び口腔内速崩壊錠
EP2465540B1 (en) * 2009-08-11 2016-10-05 Fuji Chemical Industry Co., Ltd. Disintegrating particle composition and orally rapidly disintegrating tablet
JP5663238B2 (ja) * 2009-08-31 2015-02-04 ライオン株式会社 内服固形製剤及びその製造方法
JP2011157348A (ja) * 2010-01-05 2011-08-18 Fuji Chem Ind Co Ltd 崩壊性高強度球状粒子組成物
JP5711520B2 (ja) 2010-01-06 2015-04-30 三洋化成工業株式会社 外用組成物
US20110218216A1 (en) 2010-01-29 2011-09-08 Kumaravel Vivek Extended release pharmaceutical composition of donepezil
JP2012079118A (ja) 2010-10-01 2012-04-19 Toyota Motor Corp 走行支援装置及び方法
PL2651415T3 (pl) 2010-12-13 2021-04-19 Rite-Prep Pty Ltd. Formulacje dożołądkowe i dookrężnicze oraz sposoby ich wytwarzania i zastosowania
AU2012327212B2 (en) 2011-10-27 2016-05-12 Rite-Prep Pty Ltd Electrolyte purgatives
HUE043852T2 (hu) 2012-07-27 2019-09-30 Redhill Biopharma Ltd A vastagbél kiürítésére szolgáló készítmények és a készítmények elõállítási módszerei
BR112015004165A2 (pt) 2012-08-29 2017-07-04 Salix Pharmaceuticals Inc métodos e composições laxantes para o tratamento de constipação e condições e doenças gastrointestinais relacionadas

Also Published As

Publication number Publication date
MX366707B (es) 2019-07-22
PH12015500165A1 (en) 2015-03-16
KR20150044027A (ko) 2015-04-23
WO2014016671A2 (en) 2014-01-30
CN104797244B (zh) 2018-03-09
RU2015106688A (ru) 2016-09-20
TR201904884T4 (tr) 2019-05-21
US11058671B2 (en) 2021-07-13
EP2877163A4 (en) 2015-12-09
NZ704014A (en) 2017-10-27
CA2880282A1 (en) 2014-01-30
IN2015DN00637A (hu) 2015-06-26
JP2015522652A (ja) 2015-08-06
BR112015001640A2 (pt) 2017-07-04
CY1121852T1 (el) 2020-07-31
IL236791B (en) 2020-08-31
JP6454640B2 (ja) 2019-01-16
US10166219B2 (en) 2019-01-01
EP2877163B1 (en) 2019-03-20
IL236791A0 (en) 2015-03-31
KR102152873B1 (ko) 2020-09-08
ES2717282T3 (es) 2019-06-20
PL2877163T3 (pl) 2019-08-30
US20200222375A1 (en) 2020-07-16
AU2013294737B2 (en) 2018-05-24
US20190240205A1 (en) 2019-08-08
US20150272937A1 (en) 2015-10-01
DK2877163T3 (en) 2019-04-15
HRP20190550T1 (hr) 2019-05-31
US10493065B2 (en) 2019-12-03
CA2880282C (en) 2020-09-01
MX2015000971A (es) 2015-07-14
HK1212596A1 (zh) 2016-06-17
SI2877163T1 (sl) 2019-06-28
EP2877163A2 (en) 2015-06-03
WO2014016671A3 (en) 2014-03-13
CN104797244A (zh) 2015-07-22
AU2013294737A1 (en) 2015-02-05
CN108175773A (zh) 2018-06-19
PT2877163T (pt) 2019-05-24

Similar Documents

Publication Publication Date Title
HK1211468A1 (en) Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
IL252566B (en) Pharmacy preparations and methods
HK1206622A1 (en) Formulations and methods for vaginal delivery of antiprogestins
HK1202244A1 (en) Prebiotic formulations and methods of use
HK1212596A1 (zh) 用於結腸排空的製劑和製備製劑方法
EP2884984A4 (en) THERAPEUTIC COMPOSITIONS AND METHOD
HK1209636A1 (en) Trans-clomiphene formulations and uses thereof (trans-clomiphene)
IL236399B1 (en) Polymerizable compositions and methods of use in vivo
SG11201404728VA (en) Nanoparticle paste formulations and methods for production and use thereof
HK1206970A1 (en) Antigenic compositions and methods
SG10201606161UA (en) Albumin Formulation and Use
IL234906A0 (en) Colchicine compositions, methods of production and methods of using them
EP2895186A4 (en) THERAPEUTIC COMPOSITIONS AND RELATED METHODS
SG11201500047QA (en) Vacuum forming process and use
GB201218084D0 (en) Novel compounds and methods for use in medicine
IL237298A0 (en) Tri(hetero)arylpyrazoles and their uses
IL233961B (en) The composition of a phytogenic supplement and methods of its use
EP2834635A4 (en) COMPOSITIONS WITH A HEPARINE ACCUMULATIVE AND METHOD THEREFOR
GB201208315D0 (en) Pharmaceutical methods and compositions
IL229936B (en) Albumin formulation and use
GB201113314D0 (en) Formulations and processes